Pub Date : 2025-10-08eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1655726
Jian Yang, Yi Sun, Fan Li, Quanzhi Wei, Jincui Wei, Yingxiong Zhang
Background: This study evaluates the effectiveness of AI-enhanced "One Body Two Wings" pharmacovigilance models in China, focusing on improving medication safety and risk management. As the pharmaceutical landscape grows more complex, integrating AI into pharmacovigilance offers the potential to enhance adverse drug reaction (ADR) detection and monitoring.
Methods: A nationwide cross-sectional survey was conducted from June 25 to August 10, 2024, involving 1,000 participants from pharmacovigilance centers, hospitals, corporations, and the general public. Participants were recruited through stratified convenience sampling to ensure a broad geographical and professional representation. Data were collected through a validated questionnaire and analyzed using ANOVA, regression analysis, decision tree models, and random forest algorithms. To ensure the validity of the predictive models, resampling (SMOTE) and class weighting techniques were employed to address significant class imbalance in the outcome variable.
Results: The survey revealed that 43% of participants were hospital staff and 46% had more than 10 years of experience, with these expert groups expressing strong support for AI's role. Path analysis indicated that AI's effectiveness in processing ADR reports was strongly related to enhanced monitoring capabilities (standardized path coefficient: 0.85). Furthermore, logistic regression identified the perceived effectiveness of information systems as a significant predictor of positive attitudes toward the model (odds ratio: 1.703). Crucially, a random forest model, adjusted for class imbalance, confirmed that information systems effectiveness was the most significant predictor of the model's success (mean importance: 0.53 ± 0.05), achieving robust performance with a weighted F1-score of 0.94 and an AUC-ROC of 0.89.
Conclusion: The findings confirm AI's potential to enhance pharmacovigilance, especially in ADR monitoring. However, the study concludes that successful AI integration is predicated on a robust information systems infrastructure, which the data identified as the most critical foundational element. Therefore, optimizing pharmacovigilance in China requires prioritized investment in both this foundational IT and supportive organizational frameworks.
{"title":"Evaluating the effectiveness of AI-enhanced \"One Body, Two Wings\" pharmacovigilance models in China: a nationwide survey on medication safety and risk management.","authors":"Jian Yang, Yi Sun, Fan Li, Quanzhi Wei, Jincui Wei, Yingxiong Zhang","doi":"10.3389/frhs.2025.1655726","DOIUrl":"10.3389/frhs.2025.1655726","url":null,"abstract":"<p><strong>Background: </strong>This study evaluates the effectiveness of AI-enhanced \"One Body Two Wings\" pharmacovigilance models in China, focusing on improving medication safety and risk management. As the pharmaceutical landscape grows more complex, integrating AI into pharmacovigilance offers the potential to enhance adverse drug reaction (ADR) detection and monitoring.</p><p><strong>Methods: </strong>A nationwide cross-sectional survey was conducted from June 25 to August 10, 2024, involving 1,000 participants from pharmacovigilance centers, hospitals, corporations, and the general public. Participants were recruited through stratified convenience sampling to ensure a broad geographical and professional representation. Data were collected through a validated questionnaire and analyzed using ANOVA, regression analysis, decision tree models, and random forest algorithms. To ensure the validity of the predictive models, resampling (SMOTE) and class weighting techniques were employed to address significant class imbalance in the outcome variable.</p><p><strong>Results: </strong>The survey revealed that 43% of participants were hospital staff and 46% had more than 10 years of experience, with these expert groups expressing strong support for AI's role. Path analysis indicated that AI's effectiveness in processing ADR reports was strongly related to enhanced monitoring capabilities (standardized path coefficient: 0.85). Furthermore, logistic regression identified the perceived effectiveness of information systems as a significant predictor of positive attitudes toward the model (odds ratio: 1.703). Crucially, a random forest model, adjusted for class imbalance, confirmed that information systems effectiveness was the most significant predictor of the model's success (mean importance: 0.53 ± 0.05), achieving robust performance with a weighted F1-score of 0.94 and an AUC-ROC of 0.89.</p><p><strong>Conclusion: </strong>The findings confirm AI's potential to enhance pharmacovigilance, especially in ADR monitoring. However, the study concludes that successful AI integration is predicated on a robust information systems infrastructure, which the data identified as the most critical foundational element. Therefore, optimizing pharmacovigilance in China requires prioritized investment in both this foundational IT and supportive organizational frameworks.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1655726"},"PeriodicalIF":2.7,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12540474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-07eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1587795
Douglas Ziedonis, Robert A Schnoll, Orrin Myers, Thomas Anthony Chavez, Amy Bachyrycz, Cesar J Ojeda, Frank T Leone, Mackenzie Hosie Quinn, Prajakta Adsul
Introduction: Implementing evidence-based interventions for tobacco use disorder (TUD) in community mental health agencies is critical, given the low adoption rates of these interventions and the high rates of TUD among patients, contributing to the high morbidity and shortened lifespan of this population. Implementation efforts require enhancing organizational preparedness to integrate these evidence-based interventions.
Purpose: When the Addressing Tobacco Through Organizational Change (ATTOC) model was evaluated in a cluster-randomized trial (with 13 clinics, 610 clients, and 222 staff) and compared with an education-only intervention, ATTOC proved to be better at having more TUD treatment, policies, and staff skills. This paper presents a secondary analysis focusing only on the ATTOC sites, examining whether clinic-level preparedness is associated with increased implementation activities and estimating the combined direct and indirect impact on patient referrals to evidence-based TUD interventions.
Methods: Seven sites applied the ATTOC model over 9 months, with the ATTOC Environmental Scan (ES) conducted at baseline and 3, 6, and 9 months to assess the following: (1) the environment inside and outside the building, (2) staff training and personal tobacco use, (3) clinical TUD services and documentation, and (4) tobacco policies. Summary statistics are provided, and generalized linear mixed model analyses for repeated measures were used to assess time trends and relationships among composite preparedness, activities, and number of referrals.
Results: Over the 9-month period, significant improvements were observed in ES composite preparedness (p < 0.001) and individual ES areas (p < 0.001 for each). Eight out of 11 ATTOC Dashboard items showed significant changes, including increased number of patients treated (p = 0.002); tobacco discussions (p = 0.022); provision of educational brochures (p = 0.034); referrals to a Nicotine Anonymous group (p < 0.001), an in-house wellness or tobacco group (p < 0.001), and state quitline (p = 0.012); and documentation in treatment plans (p = 0.008). Both composite preparedness (p = 0.006) and composite activities (p < 0.001) were significantly associated with the number of composite referrals.
Conclusion: Significant TUD intervention uptake was found over time through the ATTOC model organizational change intervention and tracking tools.
在社区精神卫生机构实施基于证据的烟草使用障碍(TUD)干预措施至关重要,因为这些干预措施的采用率低,而患者中TUD的发生率高,导致这一人群的高发病率和寿命缩短。实施工作需要加强组织准备,以整合这些以证据为基础的干预措施。目的:通过组织变革解决烟草问题(ATTOC)模型在一项集群随机试验(13家诊所,610名客户和222名工作人员)中进行评估,并与仅进行教育干预相比,ATTOC在更多的TUD治疗、政策和工作人员技能方面表现更好。本文提出了一项仅关注ATTOC站点的二次分析,检查临床水平的准备是否与增加的实施活动有关,并估计对患者转诊到循证TUD干预措施的直接和间接综合影响。方法:七个站点在9个月内应用了ATTOC模型,并在基线和第3、6和9个月进行了ATTOC环境扫描(ES),以评估以下内容:(1)建筑物内外环境,(2)员工培训和个人吸烟情况,(3)临床TUD服务和文件,以及(4)烟草政策。提供了汇总统计数据,并使用重复测量的广义线性混合模型分析来评估复合准备,活动和转诊数量之间的时间趋势和关系。结果:在9个月的时间里,观察到ES复合准备的显著改善(p p p = 0.002);烟草讨论(p = 0.022);提供教育小册子(p = 0.034);转介到尼古丁匿名小组(p p p = 0.012);治疗方案的记录(p = 0.008)。结论:通过ATTOC模型、组织变革干预和跟踪工具,随着时间的推移,发现显著的TUD干预吸收。
{"title":"Use of organizational change strategies and personalized agency feedback improves addressing tobacco in behavioral health outpatient treatment settings.","authors":"Douglas Ziedonis, Robert A Schnoll, Orrin Myers, Thomas Anthony Chavez, Amy Bachyrycz, Cesar J Ojeda, Frank T Leone, Mackenzie Hosie Quinn, Prajakta Adsul","doi":"10.3389/frhs.2025.1587795","DOIUrl":"10.3389/frhs.2025.1587795","url":null,"abstract":"<p><strong>Introduction: </strong>Implementing evidence-based interventions for tobacco use disorder (TUD) in community mental health agencies is critical, given the low adoption rates of these interventions and the high rates of TUD among patients, contributing to the high morbidity and shortened lifespan of this population. Implementation efforts require enhancing organizational preparedness to integrate these evidence-based interventions.</p><p><strong>Purpose: </strong>When the Addressing Tobacco Through Organizational Change (ATTOC) model was evaluated in a cluster-randomized trial (with 13 clinics, 610 clients, and 222 staff) and compared with an education-only intervention, ATTOC proved to be better at having more TUD treatment, policies, and staff skills. This paper presents a secondary analysis focusing only on the ATTOC sites, examining whether clinic-level preparedness is associated with increased implementation activities and estimating the combined direct and indirect impact on patient referrals to evidence-based TUD interventions.</p><p><strong>Methods: </strong>Seven sites applied the ATTOC model over 9 months, with the ATTOC Environmental Scan (ES) conducted at baseline and 3, 6, and 9 months to assess the following: (1) the environment inside and outside the building, (2) staff training and personal tobacco use, (3) clinical TUD services and documentation, and (4) tobacco policies. Summary statistics are provided, and generalized linear mixed model analyses for repeated measures were used to assess time trends and relationships among composite preparedness, activities, and number of referrals.</p><p><strong>Results: </strong>Over the 9-month period, significant improvements were observed in ES composite preparedness (<i>p</i> < 0.001) and individual ES areas (<i>p</i> < 0.001 for each). Eight out of 11 ATTOC Dashboard items showed significant changes, including increased number of patients treated (<i>p</i> = 0.002); tobacco discussions (<i>p</i> = 0.022); provision of educational brochures (<i>p</i> = 0.034); referrals to a Nicotine Anonymous group (<i>p</i> < 0.001), an in-house wellness or tobacco group (<i>p</i> < 0.001), and state quitline (<i>p</i> = 0.012); and documentation in treatment plans (<i>p</i> = 0.008). Both composite preparedness (<i>p</i> = 0.006) and composite activities (<i>p</i> < 0.001) were significantly associated with the number of composite referrals.</p><p><strong>Conclusion: </strong>Significant TUD intervention uptake was found over time through the ATTOC model organizational change intervention and tracking tools.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1587795"},"PeriodicalIF":2.7,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145350480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Introduction: </strong>The COVID-19 pandemic both exposed and exacerbated the multiple pre-existing societal inequities for disabled people and those from minoritised ethnic groups in the UK, especially those who were on temporary visas, or were asylum seekers or undocumented migrants. Inequities in their health and social care were marked and poorly managed. Therefore, within the mixed-methods CICADA study, we explored their person-centred health and social care, with the primary aim of making recommendations for its improvement, focusing on the intersection of ethnicity, disability, and citizenship status. We used embodiment models of disability with an assets/strengths-based approach to develop useful person-centred solutions to issues. Person-centred care prioritises individuals' diverse contexts and their inclusion in care decisions, thus its improvement is particularly suited to participatory research methods which formed a substantial component of the CICADA study; this alignment is the paper's focus as a methodological discussion.</p><p><strong>Methods: </strong>Within the qualitative strand of the study, the topic of this paper, one aim was to explore the effectiveness of different types of collaborative approaches in successfully including recent migrants. Co-researchers from minoritised communities worked autonomously alongside the central team to conduct semi-structured interviews across England. Two community groups, working independently in parallel, interviewed further participants, produced autonomous reports, and helped practically. The study's public advisory group (PAG) joined the co-researcher team to facilitate knowledge exchange workshops (to develop mutual understanding) and mixed patient-professional co-design sessions (for patient-centred outputs and interventions).</p><p><strong>Results: </strong>The mix of different participatory methods proved an effective research approach and enabled the involvement of undocumented migrants and those of precarious migration status who would be excluded by other approaches. We were able to show, for example, how recent and undocumented migrants navigated UK healthcare systems with difficulty, meeting systemic cultural, bureaucratic and socioeconomic barriers that led to patient-provider misalignment rather than person-centred care. Co-design workshops produced collaboratively designed solutions, including improved communication strategies.</p><p><strong>Discussion: </strong>The CICADA study underscored the importance of participatory methods in developing more person-centred care, by addressing structural inequities in research involvement that mirror those within health and social care services. It also showed the significance of choosing different participatory approaches depending on the specific needs, and some issues with their use in practice. Institutional constraints, such as funding and bureaucratic barriers, and time limitations, posed challenges to fully realisin
{"title":"Working in partnership with people from under-represented groups to develop person-centred social and health care practices: methodological insights from the CICADA study.","authors":"Carol Rivas, Amanda P Moore, Kusha Anand, Feryal Awan, Samina Begum, Neelam Heera, Sarabajaya Kumar, Sudhir Shah, Yesmin Shahid, Alison Thomson","doi":"10.3389/frhs.2025.1563354","DOIUrl":"10.3389/frhs.2025.1563354","url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic both exposed and exacerbated the multiple pre-existing societal inequities for disabled people and those from minoritised ethnic groups in the UK, especially those who were on temporary visas, or were asylum seekers or undocumented migrants. Inequities in their health and social care were marked and poorly managed. Therefore, within the mixed-methods CICADA study, we explored their person-centred health and social care, with the primary aim of making recommendations for its improvement, focusing on the intersection of ethnicity, disability, and citizenship status. We used embodiment models of disability with an assets/strengths-based approach to develop useful person-centred solutions to issues. Person-centred care prioritises individuals' diverse contexts and their inclusion in care decisions, thus its improvement is particularly suited to participatory research methods which formed a substantial component of the CICADA study; this alignment is the paper's focus as a methodological discussion.</p><p><strong>Methods: </strong>Within the qualitative strand of the study, the topic of this paper, one aim was to explore the effectiveness of different types of collaborative approaches in successfully including recent migrants. Co-researchers from minoritised communities worked autonomously alongside the central team to conduct semi-structured interviews across England. Two community groups, working independently in parallel, interviewed further participants, produced autonomous reports, and helped practically. The study's public advisory group (PAG) joined the co-researcher team to facilitate knowledge exchange workshops (to develop mutual understanding) and mixed patient-professional co-design sessions (for patient-centred outputs and interventions).</p><p><strong>Results: </strong>The mix of different participatory methods proved an effective research approach and enabled the involvement of undocumented migrants and those of precarious migration status who would be excluded by other approaches. We were able to show, for example, how recent and undocumented migrants navigated UK healthcare systems with difficulty, meeting systemic cultural, bureaucratic and socioeconomic barriers that led to patient-provider misalignment rather than person-centred care. Co-design workshops produced collaboratively designed solutions, including improved communication strategies.</p><p><strong>Discussion: </strong>The CICADA study underscored the importance of participatory methods in developing more person-centred care, by addressing structural inequities in research involvement that mirror those within health and social care services. It also showed the significance of choosing different participatory approaches depending on the specific needs, and some issues with their use in practice. Institutional constraints, such as funding and bureaucratic barriers, and time limitations, posed challenges to fully realisin","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1563354"},"PeriodicalIF":2.7,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537680/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145350516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-03eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1663682
Yuhan Cheng, Sibei Wan, Yifan Jiang, Yi Sheng, Qian Wu, Yan Shi, Li Wang
Objective: To explore nurse role reconstruction under the implementation of no-attendant care services in Shanghai hospitals, and to identify challenges and strategies for optimization.
Methods: A phenomenological qualitative design was adopted. From June 1 to July 1, 2025, semi-structured face-to-face interviews were conducted with 14 registered nurses from no-attendant care wards in three tertiary hospitals in Shanghai. Data were transcribed verbatim and analyzed using Colaizzi's seven-step method. Two researchers independently coded, discrepancies were resolved through discussion and methodological arbitration, and results were validated through member checking to ensure rigor.
Results: Four main themes and eleven subthemes were extracted: (1) Expanded Responsibilities and Intensified Workload: Significant Increase in Work Intensity; New Challenges in Professional Competence; Multidimensional Accumulation of Occupational Stress. (2) Positive Impacts on Patients and Families: Effective Relief of Family Care Burden; Enhanced Perceived Value of High-Quality Nursing. (3) Challenges in the Implementation Process: Blind Spots in Patient Safety Management; Need to Improve Nurse-Patient Communication Efficiency; Inadequate Mechanisms for Accountability. (4) Optimization Strategies: Establish a Legal Safeguard System; Improve Insurance Payment Coordination Mechanism; Strengthen Training Mechanisms for Nursing Assistants. A few minority or dissenting perspectives were incorporated as contextual modifiers.
Conclusion: No-attendant care improves patient experience and alleviates family caregiving burden, but simultaneously places heavier physical, risk, and relational demands on nurses, highlighting the complexity of role reconstruction. This study demonstrates the essential features of nurses' lived experiences under this model and emphasizes the need for systemic support, such as legal frameworks, insurance coverage, and workforce training, to optimize care delivery and sustain professional resilience.
{"title":"The real experience of nurse role reconstruction under the implementation of the no-attendant care policy in Shanghai hospitals: a qualitative study.","authors":"Yuhan Cheng, Sibei Wan, Yifan Jiang, Yi Sheng, Qian Wu, Yan Shi, Li Wang","doi":"10.3389/frhs.2025.1663682","DOIUrl":"10.3389/frhs.2025.1663682","url":null,"abstract":"<p><strong>Objective: </strong>To explore nurse role reconstruction under the implementation of no-attendant care services in Shanghai hospitals, and to identify challenges and strategies for optimization.</p><p><strong>Methods: </strong>A phenomenological qualitative design was adopted. From June 1 to July 1, 2025, semi-structured face-to-face interviews were conducted with 14 registered nurses from no-attendant care wards in three tertiary hospitals in Shanghai. Data were transcribed verbatim and analyzed using Colaizzi's seven-step method. Two researchers independently coded, discrepancies were resolved through discussion and methodological arbitration, and results were validated through member checking to ensure rigor.</p><p><strong>Results: </strong>Four main themes and eleven subthemes were extracted: (1) Expanded Responsibilities and Intensified Workload: Significant Increase in Work Intensity; New Challenges in Professional Competence; Multidimensional Accumulation of Occupational Stress. (2) Positive Impacts on Patients and Families: Effective Relief of Family Care Burden; Enhanced Perceived Value of High-Quality Nursing. (3) Challenges in the Implementation Process: Blind Spots in Patient Safety Management; Need to Improve Nurse-Patient Communication Efficiency; Inadequate Mechanisms for Accountability. (4) Optimization Strategies: Establish a Legal Safeguard System; Improve Insurance Payment Coordination Mechanism; Strengthen Training Mechanisms for Nursing Assistants. A few minority or dissenting perspectives were incorporated as contextual modifiers.</p><p><strong>Conclusion: </strong>No-attendant care improves patient experience and alleviates family caregiving burden, but simultaneously places heavier physical, risk, and relational demands on nurses, highlighting the complexity of role reconstruction. This study demonstrates the essential features of nurses' lived experiences under this model and emphasizes the need for systemic support, such as legal frameworks, insurance coverage, and workforce training, to optimize care delivery and sustain professional resilience.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1663682"},"PeriodicalIF":2.7,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Globally adopted as a contemporary hospital management methodology, DRG payment systems aim to improve cost-efficiency, advance clinical service quality, and maintain treatment safety. Through empirical analysis of lung cancer inpatient data, this study quantifies the policy's effects on medical expenditure patterns and efficiency metrics, offering evidence-based insights for optimizing healthcare resource management.
Methods: Using ITS analysis, we developed a segmented regression model to evaluate the longitudinal effects of DRG-based payment reform on healthcare expenditure and LOS for lung cancer patients at a regional tertiary hospital in Northwest China.
Results: The analytical cohort comprised 1,076 consecutively admitted lung cancer patients. ITS analysis revealed: (1) No significant immediate changes in total hospitalization costs (β2 = -1,365.532, P = 0.684), treatment expenses [(β2 = +147.512, P = 0.524)], or LOS [(β2 = -0.104 days, P = 0.944)], with stable longitudinal trends post-implementation; (2) Material expenses showed no reduction [(β2 = -1,433.072, P = 0.426)]; (3) Diagnosis expenses exhibited a significant immediate increase [(β2 = +1,953.740, P < 0.001)] and progressive monthly escalation [(β3 = +72.184, P = 0.035)], while drug costs showed a pronounced policy-induced surge [(β2 = +4,963.668, P < 0.001)] with accelerated growth [(β3 =+147.378 per month, P = 0.001)].
Conclusion: While DRG reform serves as an essential resource allocation mechanism, our findings reveal paradoxical outcomes. The implementation showed limited efficacy in reducing aggregate costs and LOS while provoking structural cost shifts marked by escalated diagnostic and pharmaceutical expenditures. These unintended economic consequences may distort clinical practices, potentially compromising both pharmacoeconomic efficiency and service quality.
目的:作为一种现代医院管理方法,DRG支付系统在全球范围内被采用,旨在提高成本效益,提高临床服务质量,维护治疗安全。本研究通过对肺癌住院患者数据的实证分析,量化政策对医疗支出模式和效率指标的影响,为优化医疗资源管理提供循证见解。方法:采用ITS分析方法,建立分段回归模型,对西北地区某区域性三级医院基于drg的支付改革对肺癌患者医疗费用和住院时间的纵向影响进行评价。结果:分析队列包括1076例连续入院的肺癌患者。ITS分析显示:(1)总住院费用(β 2 = -1,365.532, P = 0.684)、治疗费用[(β 2 = +147.512, P = 0.524)]、住院时间(LOS) [(β 2 = -0.104天,P = 0.944)]即刻无显著变化,实施后纵向趋势稳定;(2)材料费用没有减少[(β 2 = - 1433.072, P = 0.426)];(3)诊断费用立即显著增加[(β 2 =+ 1,953.740, P β 3 =+ 72.184, P = 0.035)],而药品费用则因政策而显著增加[(β 2 =+ 4,963.668, P β 3 =+147.378, P = 0.001)]。结论:虽然DRG改革是一种重要的资源配置机制,但我们的研究结果揭示了矛盾的结果。实施表明,在降低总成本和LOS方面效果有限,同时引发了以诊断和药品支出升级为标志的结构性成本转移。这些意想不到的经济后果可能扭曲临床实践,潜在地损害药物经济效率和服务质量。
{"title":"Impact analysis of DRG payment reform on hospitalization expenses and length of stay for lung cancer inpatients (2019-2023).","authors":"Mingbo Chen, Dongfeng Pan, Ting Pan, Zhuo Liu, Yuhui Geng, Xiaojuan Ma, Peifeng Liang","doi":"10.3389/frhs.2025.1661995","DOIUrl":"10.3389/frhs.2025.1661995","url":null,"abstract":"<p><strong>Objective: </strong>Globally adopted as a contemporary hospital management methodology, DRG payment systems aim to improve cost-efficiency, advance clinical service quality, and maintain treatment safety. Through empirical analysis of lung cancer inpatient data, this study quantifies the policy's effects on medical expenditure patterns and efficiency metrics, offering evidence-based insights for optimizing healthcare resource management.</p><p><strong>Methods: </strong>Using ITS analysis, we developed a segmented regression model to evaluate the longitudinal effects of DRG-based payment reform on healthcare expenditure and LOS for lung cancer patients at a regional tertiary hospital in Northwest China.</p><p><strong>Results: </strong>The analytical cohort comprised 1,076 consecutively admitted lung cancer patients. ITS analysis revealed: (1) No significant immediate changes in total hospitalization costs (<i>β</i> <sub>2</sub> = -1,365.532, <i>P</i> = 0.684), treatment expenses [(<i>β</i> <sub>2</sub> = +147.512, <i>P</i> = 0.524)], or LOS [(<i>β</i> <sub>2</sub> = -0.104 days, <i>P</i> = 0.944)], with stable longitudinal trends post-implementation; (2) Material expenses showed no reduction [(<i>β</i> <sub>2</sub> = -1,433.072, <i>P</i> = 0.426)]; (3) Diagnosis expenses exhibited a significant immediate increase [(<i>β</i> <sub>2</sub> = +1,953.740, <i>P</i> < 0.001)] and progressive monthly escalation [(<i>β</i> <sub>3</sub> = +72.184, <i>P</i> = 0.035)], while drug costs showed a pronounced policy-induced surge [(<i>β</i> <sub>2</sub> = +4,963.668, <i>P</i> < 0.001)] with accelerated growth [(<i>β</i> <sub>3</sub> =+147.378 per month, <i>P</i> = 0.001)].</p><p><strong>Conclusion: </strong>While DRG reform serves as an essential resource allocation mechanism, our findings reveal paradoxical outcomes. The implementation showed limited efficacy in reducing aggregate costs and LOS while provoking structural cost shifts marked by escalated diagnostic and pharmaceutical expenditures. These unintended economic consequences may distort clinical practices, potentially compromising both pharmacoeconomic efficiency and service quality.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1661995"},"PeriodicalIF":2.7,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-02eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1497055
Preston Long, Alize Rogge, Ann-Kristin Porth, Evelyn Gross, Liselotte Fierens, Belle H de Rooij, Nadia Kamminga, Tanja Stamm
Objectives: Patient-reported outcomes (PROs) are an essential component in the implementation of value-based health care. Up to now, no consensus exists on the appropriateness of PROs used across diseases, e.g., to allow for comparability or to assess disease impact. The aim of this study was to develop an international, multi-stakeholder consensus on a generic PRO set applicable for different stakeholders and diseases within of the Health Outcomes Observatory (H2O) project funded by the EU Innovative Medicines Initiative.
Methods: To begin, a literature review was conducted to identify the most frequently utilized generic PROs followed by a three-round Delphi consensus procedure. The resulting outcome set was then cross-referenced with disease-specific outcome sets for lung and metastatic breast cancer, diabetes, and inflammatory bowel diseases to identify overlaps and gaps. Lastly, the identified generic outcome domains were mapped to the Max Neef's human needs model to explore the degree to which the generic domains address a general concept of wellbeing.
Results: The literature search resulted in 2357 articles from which 190 PROMs and their measured domains were extracted. The Delphi consensus procedure reduced these to 10 core domains (mental, physical and social wellbeing, overall health status, fatigue, pain, sleep quality, sexuality, self-efficacy, treatment satisfaction). In comparison to the human needs model, needs such as identity and leisure were disregarded.
Conclusions: The H2O generic outcome set presents a disease-generic, domain-centered PRO framework building the groundwork for health data spaces and supporting consistency in treatment outcomes across different sites, settings, and patient populations.
{"title":"Standardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set.","authors":"Preston Long, Alize Rogge, Ann-Kristin Porth, Evelyn Gross, Liselotte Fierens, Belle H de Rooij, Nadia Kamminga, Tanja Stamm","doi":"10.3389/frhs.2025.1497055","DOIUrl":"10.3389/frhs.2025.1497055","url":null,"abstract":"<p><strong>Objectives: </strong>Patient-reported outcomes (PROs) are an essential component in the implementation of value-based health care. Up to now, no consensus exists on the appropriateness of PROs used across diseases, e.g., to allow for comparability or to assess disease impact. The aim of this study was to develop an international, multi-stakeholder consensus on a generic PRO set applicable for different stakeholders and diseases within of the Health Outcomes Observatory (H2O) project funded by the EU Innovative Medicines Initiative.</p><p><strong>Methods: </strong>To begin, a literature review was conducted to identify the most frequently utilized generic PROs followed by a three-round Delphi consensus procedure. The resulting outcome set was then cross-referenced with disease-specific outcome sets for lung and metastatic breast cancer, diabetes, and inflammatory bowel diseases to identify overlaps and gaps. Lastly, the identified generic outcome domains were mapped to the Max Neef's human needs model to explore the degree to which the generic domains address a general concept of wellbeing.</p><p><strong>Results: </strong>The literature search resulted in 2357 articles from which 190 PROMs and their measured domains were extracted. The Delphi consensus procedure reduced these to 10 core domains (mental, physical and social wellbeing, overall health status, fatigue, pain, sleep quality, sexuality, self-efficacy, treatment satisfaction). In comparison to the human needs model, needs such as identity and leisure were disregarded.</p><p><strong>Conclusions: </strong>The H2O generic outcome set presents a disease-generic, domain-centered PRO framework building the groundwork for health data spaces and supporting consistency in treatment outcomes across different sites, settings, and patient populations.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1497055"},"PeriodicalIF":2.7,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12528166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-02eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1638587
Anmol Shahid, Kristen Graham, Karen Benzies
This community case study outlines the conceptualization, development, implementation, and commercialization of the Alberta Family Integrated Care (Alberta FICare) model, offering insights into a unique way of sustaining patient-oriented innovations through social enterprise. Our team developed the Alberta FICare model to include families as partners in care in neonatal intensive care units (NICUs). Research phases of our model showed improved outcomes for neonates (shorter hospital stays), their families (greater caregiving self-efficacy, reduced psychosocial distress), and the health system (cost avoidance). Despite co-development of the model with families, providers, and leaders, rigorous testing (cluster randomized controlled trial), and province-wide scale-up (now standard of care in all 14 Alberta NICUs) efforts to sustain the model stalled due to shifting health system priorities. To address this challenge, we incorporated a social enterprise (Liminality Innovations Inc.) to sustain the model of care and support broader dissemination of family integrated care practices in NICUs beyond Alberta. While this strategy fostered sustainment and growth of our model, it also raised challenges. Some of these challenges included tackling perceptions within the research and practice communities that commercialization undermines research integrity. We share our experiences to highlight the potential of ethical, mission-driven commercialization through social enterprise to support innovation in learning health systems through ongoing interest holder engagement, responsible stewardship, and improving learning health system outcomes as the central goal.
{"title":"Social enterprise as a strategy to advance patient-oriented health services innovation: learning from the Alberta Family Integrated Care model.","authors":"Anmol Shahid, Kristen Graham, Karen Benzies","doi":"10.3389/frhs.2025.1638587","DOIUrl":"10.3389/frhs.2025.1638587","url":null,"abstract":"<p><p>This community case study outlines the conceptualization, development, implementation, and commercialization of the Alberta Family Integrated Care (Alberta FICare) model, offering insights into a unique way of sustaining patient-oriented innovations through social enterprise. Our team developed the Alberta FICare model to include families as partners in care in neonatal intensive care units (NICUs). Research phases of our model showed improved outcomes for neonates (shorter hospital stays), their families (greater caregiving self-efficacy, reduced psychosocial distress), and the health system (cost avoidance). Despite co-development of the model with families, providers, and leaders, rigorous testing (cluster randomized controlled trial), and province-wide scale-up (now standard of care in all 14 Alberta NICUs) efforts to sustain the model stalled due to shifting health system priorities. To address this challenge, we incorporated a social enterprise <i>(Liminality Innovations Inc.)</i> to sustain the model of care and support broader dissemination of family integrated care practices in NICUs beyond Alberta. While this strategy fostered sustainment and growth of our model, it also raised challenges. Some of these challenges included tackling perceptions within the research and practice communities that commercialization undermines research integrity. We share our experiences to highlight the potential of ethical, mission-driven commercialization through social enterprise to support innovation in learning health systems through ongoing interest holder engagement, responsible stewardship, and improving learning health system outcomes as the central goal.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1638587"},"PeriodicalIF":2.7,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12528214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-02eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1644419
Jennifer Hall, Katie H Atmore, Rimma Belikova, Chris Boyd-Skinner, Lisa Corrigan, Anastasia Giannaki, Ana Isabel F Guerreiro, Penny Kalpaxi, Colette Kelly, Konstantinos Kotsis, Dennis Ougrin, Catalina Popoviciu, Anne Marie Råberg Christensen, Dion Ras, Cassie Redlich, Tatiana Taylor Salisbury, Raffaella Sibilio, Ana Maria Tijerino, Ledia Lazeri, Joao Breda
Background: Child and youth mental health care is of varying quality across the WHO European Region, with many settings being low-resourced. To improve and standardize quality of care, WHO Regional Office for Europe is developing quality standards for child and youth mental health services. This research aims to develop evidence informed methods to develop these quality standards.
Methods: Desk reviews of grey literature aimed to understand what approaches have been used or recommended to develop quality standards for child and youth mental health/health for use across a range of different countries, and consultation was sought from an expert steering group. A thematic approach was used to synthesize relevant themes. The methods were developed based on the results of these steps.
Results: Desk reviews identified variation in approaches used and recommended to develop quality standards, with limited available guidance applicable across different resource settings. Nine key themes from stakeholder consultations were highlighted. Based on these results, a seven-step methodology was created to develop the quality standards for child and youth mental health which prioritizes using an evidence-based approach and inputs from a wide range of stakeholders.
Discussion: The methods taken to develop quality standards need to be rigorous to ensure that standards accurately define high-quality care for a service. There is a need to develop a unified approach to developing quality standards. It is hoped that this paper will provide inspiration for others developing quality standards for child and youth mental health services and spark research in this area.
{"title":"Development of methods for WHO quality standards for child and youth mental health services to improve quality of care and patient safety in the WHO European region.","authors":"Jennifer Hall, Katie H Atmore, Rimma Belikova, Chris Boyd-Skinner, Lisa Corrigan, Anastasia Giannaki, Ana Isabel F Guerreiro, Penny Kalpaxi, Colette Kelly, Konstantinos Kotsis, Dennis Ougrin, Catalina Popoviciu, Anne Marie Råberg Christensen, Dion Ras, Cassie Redlich, Tatiana Taylor Salisbury, Raffaella Sibilio, Ana Maria Tijerino, Ledia Lazeri, Joao Breda","doi":"10.3389/frhs.2025.1644419","DOIUrl":"10.3389/frhs.2025.1644419","url":null,"abstract":"<p><strong>Background: </strong>Child and youth mental health care is of varying quality across the WHO European Region, with many settings being low-resourced. To improve and standardize quality of care, WHO Regional Office for Europe is developing quality standards for child and youth mental health services. This research aims to develop evidence informed methods to develop these quality standards.</p><p><strong>Methods: </strong>Desk reviews of grey literature aimed to understand what approaches have been used or recommended to develop quality standards for child and youth mental health/health for use across a range of different countries, and consultation was sought from an expert steering group. A thematic approach was used to synthesize relevant themes. The methods were developed based on the results of these steps.</p><p><strong>Results: </strong>Desk reviews identified variation in approaches used and recommended to develop quality standards, with limited available guidance applicable across different resource settings. Nine key themes from stakeholder consultations were highlighted. Based on these results, a seven-step methodology was created to develop the quality standards for child and youth mental health which prioritizes using an evidence-based approach and inputs from a wide range of stakeholders.</p><p><strong>Discussion: </strong>The methods taken to develop quality standards need to be rigorous to ensure that standards accurately define high-quality care for a service. There is a need to develop a unified approach to developing quality standards. It is hoped that this paper will provide inspiration for others developing quality standards for child and youth mental health services and spark research in this area.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1644419"},"PeriodicalIF":2.7,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12528165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1654520
Jean-Pierre Rothen, Florence Moerlen, Céline von Büren, Samuel Allemann, Isabelle Arnet
Introduction: Ulcerative colitis is an inflammatory bowel disease that is limited to the colon. First-line treatment consists of rectally administered suppositories, foam or enema. Adherence to rectal treatment is very low in people with ulcerative colitis. We aimed to explore modifiable factors influencing adherence to rectal treatment among patients, healthcare providers (HCP), and pharmaceutical companies, and to delineate new approaches to improve adherence to rectal medicines.
Methods: We recruited people using rectal treatment, community and clinical pharmacists, gastroenterologists, inflammatory bowel diseases (IBD) nurses, and representatives of pharmaceutical companies specialised in the production of rectal therapies. We performed semi-structured one-to-one interviews tackling the three pivotal topics knowledge and beliefs, product characteristics, and communication. We started with patient interviews whose statements served to inform the other interviews. All interviews were the subject of a keyword protocol, audio-recorded, and transcribed. Thematic analysis was used with inductive approach for the patients, and deductive approach for all other interviewees. Identified themes were compared and agreements and divergences were compiled.
Results: We interviewed eight patients (22-77 years old, 3 women) in spring 2023, and stakeholders from the hospital (3 gastroenterologists and 2 IBD nurses), ambulatory setting (4 community pharmacists) and pharmaceutical companies (2 representatives) in 2024, all in the region of Basel (Switzerland). Overall, people with ulcerative colitis often feel left alone to cope with the challenges associated with their therapies. Pretreatment concerns and difficulties experienced by these people following their first attempts at use are not adequately addressed by HCPs. Training sessions for clinicians and pharmacists, patient-oriented demonstration materials, visual aids, and tips and tricks the application of rectal treatment could help improve the use of rectal medicines by people with ulcerative colitis.
Conclusion: This study identified a detailed knowledge of the proper use of rectal treatment and frank communication between patients and HCPs as crucial for the adherence to rectally administered medicines. While these factors are broadly recognised in the literature, this study highlights their common priority among all stakeholders. In addition, solutions for future development and tailored interventions are proposed.
{"title":"Rectal treatment in ulcerative colitis; a qualitative study exploring reasons for under utilisation.","authors":"Jean-Pierre Rothen, Florence Moerlen, Céline von Büren, Samuel Allemann, Isabelle Arnet","doi":"10.3389/frhs.2025.1654520","DOIUrl":"10.3389/frhs.2025.1654520","url":null,"abstract":"<p><strong>Introduction: </strong>Ulcerative colitis is an inflammatory bowel disease that is limited to the colon. First-line treatment consists of rectally administered suppositories, foam or enema. Adherence to rectal treatment is very low in people with ulcerative colitis. We aimed to explore modifiable factors influencing adherence to rectal treatment among patients, healthcare providers (HCP), and pharmaceutical companies, and to delineate new approaches to improve adherence to rectal medicines.</p><p><strong>Methods: </strong>We recruited people using rectal treatment, community and clinical pharmacists, gastroenterologists, inflammatory bowel diseases (IBD) nurses, and representatives of pharmaceutical companies specialised in the production of rectal therapies. We performed semi-structured one-to-one interviews tackling the three pivotal topics knowledge and beliefs, product characteristics, and communication. We started with patient interviews whose statements served to inform the other interviews. All interviews were the subject of a keyword protocol, audio-recorded, and transcribed. Thematic analysis was used with inductive approach for the patients, and deductive approach for all other interviewees. Identified themes were compared and agreements and divergences were compiled.</p><p><strong>Results: </strong>We interviewed eight patients (22-77 years old, 3 women) in spring 2023, and stakeholders from the hospital (3 gastroenterologists and 2 IBD nurses), ambulatory setting (4 community pharmacists) and pharmaceutical companies (2 representatives) in 2024, all in the region of Basel (Switzerland). Overall, people with ulcerative colitis often feel left alone to cope with the challenges associated with their therapies. Pretreatment concerns and difficulties experienced by these people following their first attempts at use are not adequately addressed by HCPs. Training sessions for clinicians and pharmacists, patient-oriented demonstration materials, visual aids, and tips and tricks the application of rectal treatment could help improve the use of rectal medicines by people with ulcerative colitis.</p><p><strong>Conclusion: </strong>This study identified a detailed knowledge of the proper use of rectal treatment and frank communication between patients and HCPs as crucial for the adherence to rectally administered medicines. While these factors are broadly recognised in the literature, this study highlights their common priority among all stakeholders. In addition, solutions for future development and tailored interventions are proposed.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1654520"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01eCollection Date: 2025-01-01DOI: 10.3389/frhs.2025.1664446
Virginia Mckay, Emmanuel Tetteh, Nicholas Wong, C Bradley Kramer, Jason Burnham
While there is evidence of humans' harmful impact on the environment, translating such evidence into changes is challenging. Implementation science can facilitate a shift from a reactive to proactive approach in tackling environmental sustainability. This article aims to spur further discussion among implementation scientists to incorporate environmental sustainability within their research, while also offering concepts relevant to environmental science researchers seeking to apply implementation science principles.
{"title":"Environmental sustainability, an essential outcome for implementation scientists to improve health.","authors":"Virginia Mckay, Emmanuel Tetteh, Nicholas Wong, C Bradley Kramer, Jason Burnham","doi":"10.3389/frhs.2025.1664446","DOIUrl":"10.3389/frhs.2025.1664446","url":null,"abstract":"<p><p>While there is evidence of humans' harmful impact on the environment, translating such evidence into changes is challenging. Implementation science can facilitate a shift from a reactive to proactive approach in tackling environmental sustainability. This article aims to spur further discussion among implementation scientists to incorporate environmental sustainability within their research, while also offering concepts relevant to environmental science researchers seeking to apply implementation science principles.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1664446"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}